特一药业
(002728)
| 流通市值：45.87亿 | | | 总市值：46.97亿 |
| 流通股本：5.01亿 | | | 总股本：5.13亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 393,321,980.2 | 209,871,725.36 | 924,529,614.92 | 691,850,596.25 |
| 营业总成本 | 356,299,176.39 | 178,504,163.17 | 851,118,940.49 | 626,752,024.99 |
| 其他经营收益 | | | | |
| 营业利润 | 43,040,302.29 | 35,614,412.64 | 81,150,041.35 | 73,180,076.47 |
| 利润总额 | 42,308,187.61 | 35,135,518.86 | 82,284,871.19 | 74,832,666.48 |
| 净利润 | 31,108,115.76 | 25,763,241.72 | 81,671,615.4 | 65,217,129.79 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 31,108,115.76 | 25,763,241.72 | 81,671,615.4 | 65,217,129.79 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,005,952,832.07 | 891,852,584.04 | 857,599,637.87 | 763,876,753.82 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,443,406,200.81 | 1,436,244,421.75 | 1,453,828,867.47 | 1,456,729,422.58 |
| 资产总计 | 2,449,359,032.88 | 2,328,097,005.79 | 2,311,428,505.34 | 2,220,606,176.4 |
| 流动负债: | | | | |
| 流动负债合计 | 633,337,473.89 | 443,625,672.07 | 454,334,568.72 | 380,431,919.39 |
| 非流动负债: | | | | |
| 非流动负债合计 | 36,390,703.17 | 37,187,787.51 | 35,627,936.12 | 37,239,002.05 |
| 负债合计 | 669,728,177.06 | 480,813,459.58 | 489,962,504.84 | 417,670,921.44 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,779,630,855.82 | 1,847,283,546.21 | 1,821,466,000.5 | 1,802,935,254.96 |
| 股东权益合计 | 1,779,630,855.82 | 1,847,283,546.21 | 1,821,466,000.5 | 1,802,935,254.96 |
| 负债和股东权益合计 | 2,449,359,032.88 | 2,328,097,005.79 | 2,311,428,505.34 | 2,220,606,176.4 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 462,665,917.65 | 208,366,448.25 | 993,741,388 | 769,838,274.17 |
| 经营活动现金流出小计 | 377,275,080.51 | 196,691,269.68 | 749,652,844.81 | 578,644,826.66 |
| 经营活动产生的现金流量净额 | 85,390,837.14 | 11,675,178.57 | 244,088,543.19 | 191,193,447.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 769,059,257.52 | 301,397,276.22 | 195,996,360.28 | 185,948,710.96 |
| 投资活动现金流出小计 | 761,261,590.06 | 328,446,694.94 | 484,547,293.79 | 340,854,596.88 |
| 投资活动产生的现金流量净额 | 7,797,667.46 | -27,049,418.72 | -288,550,933.51 | -154,905,885.92 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 492,271,310 | 80,000,000 | 818,386,771.7 | 587,725,358.86 |
| 筹资活动现金流出小计 | 328,252,885.18 | 50,405,704.2 | 951,249,410.46 | 742,028,826.77 |
| 筹资活动产生的现金流量净额 | 164,018,424.82 | 29,594,295.8 | -132,862,638.76 | -154,303,467.91 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 257,206,929.42 | 14,220,055.65 | -177,325,029.08 | -118,015,906.32 |
| 期末现金及现金等价物余额 | 382,843,623.83 | 139,856,750.06 | 125,636,694.41 | 184,945,817.17 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 257,206,929.42 | - | -177,325,029.08 | - |